Phosphorylation induces distinct alpha-synuclein strain formation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ma, Meng Rong ^a   Hu, Zhi Wen ^a   Zhao, Yu Fen ^a   Chen, Yong Xiang ^a   Li, Yan Mei ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; SNCA PROTEIN, HUMAN;

CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING; PROTEINOSIS; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; CELL LINE, TUMOR; HUMANS; PHOSPHORYLATION; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84995554920     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37130     Document Type: Article

References (37)

1. Lashuel, H. A., Overk, C. R., Oueslati, A., Masliah, E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38-48 (2013).
2. Goedert, M., Clavaguera, F., Tolnay, M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33, 317-325 (2010).
3. Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14, 501-503 (2008).
4. Hansen, C. et al.-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest. 121, 715-725 (2011).
5. Masuda-Suzukake, M. et al. Prion-like spreading of pathological a-synuclein in brain. Brain 136, 1128-1138 (2013).
6. Luk, K. C. et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA 106, 20051-20056 (2009).
7. Volpicelli-Daley, L. A. et al. Exogenous-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57-71 (2011).
8. Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953 (2012).
9. Guo, J. L. et al. Distinct-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103-117 (2013).
10. Bousset, L. et al. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575 (2013).
11. Peelaerts, W. et al.-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340-344 (2015).
12. Prusiner, S. B. et al. Evidence for-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl. Acad. Sci. USA. 112, E5308-E5317 (2015).
13. Woerman, A. L. et al. Propagation of prions causing synucleinopathies in cultured cells. Proc. Natl. Acad. Sci. USA 112, E4949-E4958 (2015).
14. Fujiwara, H. et al. Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell. Bio. 4, 160-164 (2002).
15. Paleologou, K. E. et al. Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. J. Biol. Chem. 283, 16895-16905 (2008).
16. Schreurs, S. et al. In Vitro Phosphorylation Does not Influence the Aggregation Kinetics of WT-Synuclein in Contrast to Its Phosphorylation Mutants. Int. J. Mol. Sci. 15, 1040-1067 (2014).
17. Samuel, F. et al. Effects of Serine 129 phosphorylation on-synuclein aggregation, membrane association, and internalization. J. Biol. Chem. 291, 4374-4385 (2016).
18. Chen, L., Feany, M. B. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci. 8, 657-663 (2005).
19. Chen, L. et al. Tyrosine and serine phosphorylation of-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J. Clin. Invest. 119, 3257-3265 (2009).
20. Sato, H. et al. Authentically phosphorylated-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease. J. Neurosci. 31, 16884-16894 (2011).
21. Shiqing, Z. et al. LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration. Sci. Rep. 5, 12564 (2015).
22. Dang, B., Kubota, T., Mandal, K., Bezanilla, F., Kent, S. B. Native chemical ligation at Asx-Cys, Glx-Cys: chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography. J. Am. Chem. Soc. 135, 11911-11919 (2013).
23. Huang, C., Ren, G., Zhou, H., Wang, C. C. A new method for purification of recombinant human alpha-synuclein in Escherichia coli. Protein Expr. Purif. 42, 173-177 (2005).
24. Bertoncini, C. W. et al. Release of long-range tertiary interaction spotentiates aggregation of natively unstructured-synuclein. Proc. Natl. Acad. Sci. USA 102, 1430-1435 (2005).
25. Murray, I. V. et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 42, 8530-8540 (2003).
26. Aguzzi, A., Heikenwalder, M., Polymenidou, M. Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 8, 552-561 (2007).
27. Yonetani, M. et al. Conversion of Wild-type-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant. J. Biol. Chem. 284, 7940-7950 (2009).
28. Vilar, M. et al. The fold of-synuclein fibrils. Proc. Natl. Acad. Sci. USA 105, 8637-8642 (2008).
29. Esteban-Martín, S., Silvestre-Ryan, J., Bertoncini, C. W., Salvatella, X. Identification of Fibril-Like Tertiary Contacts in Soluble Monomeric-Synuclein. Biophys. J. 105, 1192-1198 (2013).
30. Sasakawa, H. et al. Ultra-high field NMR studies of antibody binding and site-specific phosphorylation of-synuclein. Biochem. Biophys. Res. Commun. 363, 795-799 (2007).
31. Campioni, S. et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6, 140-147 (2010).
32. Nekooki-Machida, Y. et al. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Natl. Acad. Sci. USA 106, 9679-9684 (2009).
33. Mossuto, M. F. et al. The Non-Core Regions of Human Lysozyme Amyloid Fibrils Influence Cytotoxicity. J. Mol. Biol. 402, 783-796 (2010).
34. Xue, W. F. et al. Fibril Fragmentation Enhances Amyloid Cytotoxicity. J. Biol. Chem. 284, 34272-34282 (2009).
35. Hejjaoui, M. et al. Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: alphasynuclein phosphorylation at tyrosine 125. J. Am. Chem. Soc. 134, 5196-5210 (2012).
36. McCormack, A. L., Mak, S. K., Di Monte, D. A. Increased-synuclein phosphorylation and nitration in the aging primate substantia nigra. Cell Death Dis. 3, e315 (2012).
37. Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739-29752 (2006).